Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells

British Journal of Haematology, Supplement

Volumn 96, Issue 1, 1997, Pages 147-157

  Komada, Yoshihiro ^a   Zhou, Yan Wen ^a   Zhang, Xao Li ^a   Chen, Tong Xin ^a   Tanaka, Shigeki ^a   Azuma, Ehchi ^a   Sakurai, Minoru ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Activated T cells; Acute myelogenous leukaemia; Apoptosis; CD95; CD95 ligand

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 2; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY, IMMUNOLOGIC; DNA FRAGMENTATION; HUMANS; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LEUKEMIA, MYELOCYTIC, ACUTE; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031024850     PISSN: 09631860     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.8742505.x     Document Type: Article

References (41)

1. Anel, A., Buferne, M., Schmitt-Verhulst, A.-M. & Golstein, P. (1994) T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. European Journal of Immunology, 24, 2469-2476.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1976) Proposals for the classification of the acute leukaemias: French-American-British (FAB) co-operative group. British Journal of Haematology, 53, 451-458.
3. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. & Dixit, V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81, 505-512.
4. Chow, S.C., Weis, M., Kass, G.E.N., Holmstrom, T.M., Eriksson, J.E. & Orrenius, S. (1995) Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Letters, 364, 134-138.
5. Cleveland, J.L. & Ihle, J.N. (1995) Contenders in FasL/TNF death signaling. Cell, 81, 479-482.
6. Darmon, A.J., Nicholson, D.W. & Bleackley, R.C. (1995) Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature, 377, 446-448.
7. Enari, M., Talanian, R.V., Wong, W.W. & Nagata, S. (1996) Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature, 380, 723-726.
8. Faber, L.M., van Luxenburg-Heijs, S.A.P. Willemze, R. & Falkenburg, J.H.F. (1992) Generation of leukemia-reactive cytotoxic T lymphocytes clones from the HLA-identical bone marrow donor of a patient with leukemia. Journal of Experimental Medicine, 176, 1283-1289.
9. Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzaka, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H. & Okumura, K. (1994) Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 91, 4930-4934.
10. Haves, M.P., Berrebi, G.A. & Henkart, P.A. (1989) Induction of target cell DNA release by the cytotoxic T-lymphocyte granule protease granzyme A. Journal of Experimental Medicine, 170, 933-946.
11. Hercend, T., Takvorian, T., Nowill, A., Tantravahi, R., Moingeon, P., Anderson, K.C., Murray, C., Bohuon, C., Ythier, A. & Ritz, J. (1986) Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood, 67, 722-728.
12. Heusel, J.W., Wesselschmidt, R.L., Shresta, S., Russell, J.H. & Ley, T.J. (1994) Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 76, 977-987.
13. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E. & Bortin, M.M. (1990) Graft-versus-leukemia reaction after bone marrow transplantation. Blood, 75, 555-562.
14. Itoh, N., Tsujimoto, Y. & Nagata, S. (1993) Effect of bcl-2 on Fas antigen-mediated cell death. Journal of Immunology, 151, 621-627.
15. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y. & Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243.
16. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H. & Golstein, P. (1994) Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Nature, 265, 528-530.
17. Komada, Y. Zhou, Y.-W., Zhang, X.-L., Xue, H.-L., Sakai, H., Tanaka, S., Sakatoku, H. & Sakurai, M. (1995) Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood, 86, 3848-3860.
18. + killer cells. Blood, 86, 3493-3499.
19. Montagna, D., Arico, M., Montini, E., Benedetti, F.D. & Maccario, R. (1995) Identification of HLA-unrestricted CD8+/CD28- cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia. Cancer Research, 55, 3835-3839.
20. Naparstek, E., Or, R., Nagler, A., Cividalli, G., Engelhard, D., Aker, M., Gimon, Z., Manny, N., Sacks, T., Tochner, Z., Weiss, L., Samuel, S., Brautbar, C., Hale, G., Waldmann, H., Steinberg, S.M. & Slavin, S. (1995) T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. British Journal of Haematology, 89, 506-515.
21. Nishimura, Y., Ishii, A. & Yonehara, S. (1995) Expression and function of apoptosis antigen Fas on T lymphocytes in periphery and thymus. Leukocyte Typing V (ed. by S. F. Schlossman et al). pp. 1144-1148. Oxford University Press, Tokyo.
22. Oehm, A., Behrmann, I., Falk, W., Li-Weber, M., Maier, G., Klas, C., Richards, S., Dhein, J., Daniel, P.T., Knipping, E., Trauth, B.C., Ponstingl, H. & Krammer, P.H. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF/ NGF receptor superfamily. Journal of Biological Chemistry, 15, 10709-10715.
23. Pelfrey, C.M., Tranquill, L.R., Boehme, S.A., McFarland, H.F. & Lenardo, M.J. (1995) Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. Journal of Immunology, 154, 6191-6202.
24. h2 T cells to express Fas ligand and to undergo activation-induced cell death. International Immunology, 6, 1545-1553.
25. 2+-independent T cell-mediated cytotoxicity. Journal of Experimental Medicine, 177, 195-200.
26. Sato, T., Irie, S., Kitada, S. & Reed, J.C. (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science, 268, 411-414.
27. Shi, L. Kam, C.-M., Powers, J.C., Aebersold, R. & Greenberg, A.H. (1992) Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. Journal of Experimental Medicine, 176, 1521-1529.
28. Soiffer, R.J., Murray, C., Gonin, R. & Ritz, J. (1994) Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. Blood. 84, 964-971.
29. Sosman, J.A., Oettel, K.R., Smith, S.D., Hank, J.A., Fisch, R & Sondel, P.M. (1990) Specific recognition of human leukemic cells by allogeneic T cells. II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells. Blood, 75, 2005-2016.
30. + T-cell-mediated cytotoxicity. Journal of Immunology, 152, 1127-1233.
31. Stanger, B.Z., Leder, P., Lee, T.-H., Kim, E. & Seed, B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/ APO-1 (CD95) in yeast and causes cell death. Cell, 81, 513-523.
32. Su, B., Bochan, M.R., Hanna, W.L., Froelich, C.J. & Brahmi, Z. (1994) Human granzyme B is essential for DNA fragmentation of susceptible target cells. European Journal of Immunology, 24, 2073-2080.
33. Suda, T., Okazaki, T., Naito, Y. Yokota, T., Arai, N., Ozaki, S., Nakao, K. & Nagata, S. (1995) Expression of the Fas ligand in cells of T cell lineage. Journal of Immunology, 154, 3806-3813.
34. Sullivan, K.M., Weiden, P.L., Storb, R., Witherspoon, R.P., Fefer, R. Buckner, C.D., Anassetti, C., Appelbaum, F.R., Badger, C., Beatty, P., Bensinger, W., Berenson, B., Bigelow, C., Cheever, M.A., Clift, R., Deeg, H.J., Doney, K., Greenberg, P., Hansen, J.A., Hill, R., Loughran, T., Martin, P., Neiman, P., Peterson, F.B., Sanders, J., Singer, J., Stewart, P. & Thomas, E.D. (1989) Influence of acute graft versus host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood. 73, 1720-1728.
35. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T. & Nagata, S. (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. International Immunology, 6, 1567-1574.
36. Tan, P.H., Liu, Y., Santos, E.B. & Sandmaier, B.M. (1995) Mechanisms of enhancement of natural killer activity by an antibody to CD44: increase in conjugate formation and release of tumor necrosis factor α. Cellular Immunology, 164, 255-264.
37. Tschopp, J. & Nabholz, M. (1990) Perforin-mediated target cell lysis by cytotoxic T lymphocytes. Annual Review of Immunology, 8, 279-302.
38. Vignaux, F., Vivieir E., Malissen, B., Depraetere, V., Nagata, S. & Golstein, P. (1995) TCR/CD3 coupling to Fas-based cytotoxicity. Journal of Experimental Medicine, 181, 781-786.
39. Watanabe-Fukunaga, R., Brannan, C.I., Itoh, N., Yonehara, S., Copeland, N.G., Jenkins, N.A. & Nagata, S. (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. Journal of Immunology, 148, 1274-1279.
40. + CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. Journal of Immunology, 156, 153-159.
41. Yonehara, S., Ishii, A. & Yonehara, M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. Journal of Experimental Medicine, 169, 1747-1756.